name the disease or medical trial that has been targeted by the trials of valganciclovir (valcyte) for chronic fatigue syndrome patients who have elevated antibody titers against human herpes virus 6 (hhv-6)and epstein-barr virus (ebv).
(AND medicine.disease (JOIN medicine.disease.trials m.04d3jh_))